3.26.1 html 175 229 1 true 48 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://lanternpharma.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://lanternpharma.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://lanternpharma.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://lanternpharma.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://lanternpharma.com/role/StatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) Sheet http://lanternpharma.com/role/StatementsOfStockholdersDeficitEquity Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://lanternpharma.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 999008 - Disclosure - Organization, Principal Activities, and Basis of Presentation Sheet http://lanternpharma.com/role/OrganizationPrincipalActivitiesAndBasisOfPresentation Organization, Principal Activities, and Basis of Presentation Notes 8 false false R9.htm 999009 - Disclosure - Liquidity and Going Concern Sheet http://lanternpharma.com/role/LiquidityAndGoingConcern Liquidity and Going Concern Notes 9 false false R10.htm 999010 - Disclosure - Summary of Significant Accounting Policies Sheet http://lanternpharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 999011 - Disclosure - Commitments and Contingencies Sheet http://lanternpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 11 false false R12.htm 999012 - Disclosure - Leases Sheet http://lanternpharma.com/role/Leases Leases Notes 12 false false R13.htm 999013 - Disclosure - Stockholders’ Equity Sheet http://lanternpharma.com/role/StockholdersEquity Stockholders’ Equity Notes 13 false false R14.htm 999014 - Disclosure - Fair Value Measurements Sheet http://lanternpharma.com/role/FairValueMeasurements Fair Value Measurements Notes 14 false false R15.htm 999015 - Disclosure - Fair Value of Warrants Sheet http://lanternpharma.com/role/FairValueOfWarrants Fair Value of Warrants Notes 15 false false R16.htm 999016 - Disclosure - Loss Per Share Sheet http://lanternpharma.com/role/LossPerShare Loss Per Share Notes 16 false false R17.htm 999017 - Disclosure - Segment Reporting Sheet http://lanternpharma.com/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 999018 - Disclosure - Subsequent Event Sheet http://lanternpharma.com/role/SubsequentEvent Subsequent Event Notes 18 false false R19.htm 999019 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://lanternpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://lanternpharma.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 999020 - Disclosure - Commitments and Contingencies (Tables) Sheet http://lanternpharma.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://lanternpharma.com/role/CommitmentsAndContingencies 20 false false R21.htm 999021 - Disclosure - Leases (Tables) Sheet http://lanternpharma.com/role/LeasesTables Leases (Tables) Tables http://lanternpharma.com/role/Leases 21 false false R22.htm 999022 - Disclosure - Stockholders’ Equity (Tables) Sheet http://lanternpharma.com/role/StockholdersEquityTables Stockholders’ Equity (Tables) Tables http://lanternpharma.com/role/StockholdersEquity 22 false false R23.htm 999023 - Disclosure - Fair Value Measurements (Tables) Sheet http://lanternpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://lanternpharma.com/role/FairValueMeasurements 23 false false R24.htm 999024 - Disclosure - Fair Value of Warrants (Tables) Sheet http://lanternpharma.com/role/FairValueOfWarrantsTables Fair Value of Warrants (Tables) Tables http://lanternpharma.com/role/FairValueOfWarrants 24 false false R25.htm 999025 - Disclosure - Loss Per Share (Tables) Sheet http://lanternpharma.com/role/LossPerShareTables Loss Per Share (Tables) Tables http://lanternpharma.com/role/LossPerShare 25 false false R26.htm 999026 - Disclosure - Segment Reporting (Tables) Sheet http://lanternpharma.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://lanternpharma.com/role/SegmentReporting 26 false false R27.htm 999027 - Disclosure - Liquidity and Going Concern (Details Narrative) Sheet http://lanternpharma.com/role/LiquidityAndGoingConcernDetailsNarrative Liquidity and Going Concern (Details Narrative) Details http://lanternpharma.com/role/LiquidityAndGoingConcern 27 false false R28.htm 999028 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://lanternpharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://lanternpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies 28 false false R29.htm 999029 - Disclosure - Schedule of Research and Development (Details) Sheet http://lanternpharma.com/role/ScheduleOfResearchAndDevelopmentDetails Schedule of Research and Development (Details) Details 29 false false R30.htm 999030 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://lanternpharma.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Schedule of Accounts Payable and Accrued Liabilities (Details) Details 30 false false R31.htm 999031 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://lanternpharma.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://lanternpharma.com/role/CommitmentsAndContingenciesTables 31 false false R32.htm 999032 - Disclosure - Schedule of Balance Sheet Information Related to Leases (Details) Sheet http://lanternpharma.com/role/ScheduleOfBalanceSheetInformationRelatedToLeasesDetails Schedule of Balance Sheet Information Related to Leases (Details) Details 32 false false R33.htm 999033 - Disclosure - Schedule of Future Estimated Minimum Lease Payments Under Non-cancelable Operating Leases (Details) Sheet http://lanternpharma.com/role/ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNon-cancelableOperatingLeasesDetails Schedule of Future Estimated Minimum Lease Payments Under Non-cancelable Operating Leases (Details) Details 33 false false R34.htm 999034 - Disclosure - Schedule of Reconciliation of Right-of-Use Assets and lease Liabilities (Details) Sheet http://lanternpharma.com/role/ScheduleOfReconciliationOfRight-of-useAssetsAndLeaseLiabilitiesDetails Schedule of Reconciliation of Right-of-Use Assets and lease Liabilities (Details) Details 34 false false R35.htm 999035 - Disclosure - Schedule of Other Supplemental Information Related to Operating Leases (Details) Sheet http://lanternpharma.com/role/ScheduleOfOtherSupplementalInformationRelatedToOperatingLeasesDetails Schedule of Other Supplemental Information Related to Operating Leases (Details) Details 35 false false R36.htm 999036 - Disclosure - Schedule of Lease Expense (Details) Sheet http://lanternpharma.com/role/ScheduleOfLeaseExpenseDetails Schedule of Lease Expense (Details) Details 36 false false R37.htm 999037 - Disclosure - Leases (Details Narrative) Sheet http://lanternpharma.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://lanternpharma.com/role/LeasesTables 37 false false R38.htm 999038 - Disclosure - Schedule of Warrants Issued and Outstanding (Details) Sheet http://lanternpharma.com/role/ScheduleOfWarrantsIssuedAndOutstandingDetails Schedule of Warrants Issued and Outstanding (Details) Details 38 false false R39.htm 999039 - Disclosure - Schedule of Stock Option Activity (Details) Sheet http://lanternpharma.com/role/ScheduleOfStockOptionActivityDetails Schedule of Stock Option Activity (Details) Details 39 false false R40.htm 999040 - Disclosure - Schedule of Stock-based Compensation (Details) Sheet http://lanternpharma.com/role/ScheduleOfStock-basedCompensationDetails Schedule of Stock-based Compensation (Details) Details 40 false false R41.htm 999041 - Disclosure - Stockholders’ Equity (Details Narrative) Sheet http://lanternpharma.com/role/StockholdersEquityDetailsNarrative Stockholders’ Equity (Details Narrative) Details http://lanternpharma.com/role/StockholdersEquityTables 41 false false R42.htm 999042 - Disclosure - Schedule of Assets are Measured at Fair Value on Recurring Basis (Details) Sheet http://lanternpharma.com/role/ScheduleOfAssetsAreMeasuredAtFairValueOnRecurringBasisDetails Schedule of Assets are Measured at Fair Value on Recurring Basis (Details) Details 42 false false R43.htm 999043 - Disclosure - Schedule of Change in Fair Value of the Warrant Liability (Details) Sheet http://lanternpharma.com/role/ScheduleOfChangeInFairValueOfWarrantLiabilityDetails Schedule of Change in Fair Value of the Warrant Liability (Details) Details 43 false false R44.htm 999044 - Disclosure - Schedule of Fair Value Accounting of Warrant Activity (Details) Sheet http://lanternpharma.com/role/ScheduleOfFairValueAccountingOfWarrantActivityDetails Schedule of Fair Value Accounting of Warrant Activity (Details) Details 44 false false R45.htm 999045 - Disclosure - Fair Value Measurements (Details Narrative) Sheet http://lanternpharma.com/role/FairValueMeasurementsDetailsNarrative Fair Value Measurements (Details Narrative) Details http://lanternpharma.com/role/FairValueMeasurementsTables 45 false false R46.htm 999046 - Disclosure - Schedule of Fair Value of Warrants (Details) Sheet http://lanternpharma.com/role/ScheduleOfFairValueOfWarrantsDetails Schedule of Fair Value of Warrants (Details) Details 46 false false R47.htm 999047 - Disclosure - Schedule of Anti-dilutive Securities Outstanding Diluted Loss Per Share (Details) Sheet http://lanternpharma.com/role/ScheduleOfAnti-dilutiveSecuritiesOutstandingDilutedLossPerShareDetails Schedule of Anti-dilutive Securities Outstanding Diluted Loss Per Share (Details) Details 47 false false R48.htm 999048 - Disclosure - Schedule of Segment Reporting Information (Details) Sheet http://lanternpharma.com/role/ScheduleOfSegmentReportingInformationDetails Schedule of Segment Reporting Information (Details) Details 48 false false R49.htm 999049 - Disclosure - Segment Reporting (Details Narrative) Sheet http://lanternpharma.com/role/SegmentReportingDetailsNarrative Segment Reporting (Details Narrative) Details http://lanternpharma.com/role/SegmentReportingTables 49 false false R50.htm 999050 - Disclosure - Subsequent Event (Details Narrative) Sheet http://lanternpharma.com/role/SubsequentEventDetailsNarrative Subsequent Event (Details Narrative) Details http://lanternpharma.com/role/SubsequentEvent 50 false false All Reports Book All Reports form10-q.htm ltrn-20260630.xsd ltrn-20260630_cal.xml ltrn-20260630_def.xml ltrn-20260630_lab.xml ltrn-20260630_pre.xml http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 true true